Published: Vol 9, Iss 20, Oct 20, 2019 DOI: 10.21769/BioProtoc.3401 Views: 6022
Reviewed by: Chiara AmbrogioMuhammad AslamAnonymous reviewer(s)
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics
Related protocols
Use of Open Surface Plasmon Resonance (OpenSPR) to Characterize the Binding Affinity of Protein–Protein Interactions
Cassie Shu Zhu [...] Haichao Wang
Sep 5, 2023 1586 Views
Determination of Dissociation Constants for the Interaction of Myosin-5a with its Cargo Protein Using Microscale Thermophoresis (MST)
Rui Zhou [...] Xiang-Dong Li
Feb 5, 2025 661 Views
Cell-Sonar, an Easy and Low-cost Method to Track a Target Protein by Expression Changes of Specific Protein Markers
Sabrina Brockmöller [...] Simone Rothmiller
Feb 5, 2025 669 Views
Abstract
This protocol was designed to quantitatively measure small-molecule displacement of proteins in live mammalian cells using fluorescence lifetime imaging microscopy–Förster resonance energy transfer (FLIM-FRET). Tumour cell survival is often dependent on anti-apoptotic proteins, which bind to and inhibit pro-apoptotic proteins, thus preventing apoptosis. Small-molecule inhibitors that selectively target these proteins (termed BH3-mimetics) are therefore a promising avenue for the treatment of several cancers. Previous techniques used to study the efficacy of these drugs often use truncated versions of both pro- and anti-apoptotic proteins, as they are membrane bound and hydrophobic in nature. As a result, the true efficacy of these drugs to displace full-length pro-apoptotic proteins in their native environment within a cell is poorly understood. This protocol describes FLIM-FRET methods to directly measure the displacement (or lack of displacement) of full-length Bcl-2 family proteins in live mammalian cells.
Keywords: FLIMBackground
Tumour cell survival is dependent on anti-apoptotic proteins such as Bcl-2 and Bcl-XL, which maintain the integrity of the mitochondrial outer-membrane, thus preventing programmed cell death. Small-molecule inhibitors that selectively target these anti-apoptotic proteins (termed BH3-mimetics) are therefore a promising avenue for the treatment of several cancers. However, in order to study the efficacy of BH3-mimetics, tools to measure Bcl-2 family interactions are required. Previous techniques used to study the efficacy of these drugs often used truncated versions of Bcl-2 and Bcl-XL, as they are membrane bound and contain hydrophobic sequences that make purification difficult. However, the use of truncated proteins in vitro fails to recapitulate the whole story, since Bcl-2 family proteins often behave differently on membrane surfaces (Lovell et al., 2008; Pécot et al., 2016). Moreover, the use of detergents in immunoprecipitation of endogenous proteins can artificially promote or dissociate Bcl-2 family protein interactions (Hsu and Youle, 1997; Billen et al., 2008). Our approach is to use fluorescence lifetime imaging microscopy–Förster resonance energy transfer (FLIM-FRET), to measure full-length protein interactions in living cells (Osterlund et al., 2015; Liu et al., 2019). This is accomplished by expressing two proteins of interest in a desired cell type, with each protein fused to appropriate fluorescent proteins. As a donor fluorescent protein, we use mCerulean3 (mCer3) and as the acceptor, Venus. During a protein-protein interaction, the fluorescent proteins are in close proximity, enabling the donor fluorescent protein to non-radiatively transfer energy to the acceptor. Small molecule inhibitors that inhibit the studied protein interaction, result in a decrease in energy transfer due to a reduction in protein binding. The advantage of this technique is that it enables the use of full-length proteins interacting in their native environment within the cell. Additionally, with the use of proper controls, FLIM-FRET can distinguish true protein interactions from random collisions that occur on confined organelle-membrane surfaces (Osterlund et al., 2015). Here we describe a detailed protocol on how to collect and analyze FLIM-FRET data, as in our most recent publication (Liu et al., 2019).
Materials and Reagents
Equipment
Software
Procedure
Data analysis
Recipes
Acknowledgments
Research was funded by Canadian Institutes of Health Foundation grant FRN 12517 to DWA who also holds a Tier 1 Canada Research Chair in membrane biogenesis. The protocol described here is based on research previously published in Osterlund et al. (2015) and Liu et al. (2019).
Competing interests
The authors declare that they have no financial or non-financial competing interests.
References
Article Information
Copyright
Pemberton et al. This article is distributed under the terms of the Creative Commons Attribution License (CC BY 4.0).
How to cite
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
Category
Biochemistry > Protein > Interaction
Cancer Biology > Cancer biochemistry > Drug resistance
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link